Roongrojwittayakul, Sirawit
Anukoolwittaya, Prakit
Hiransuthikul, Akarin
Pongpitakmetha, Thanakit
Thanprasertsuk, Sekh
Rattanawong, Wanakorn
Article History
Received: 16 June 2025
Accepted: 18 September 2025
First Online: 17 October 2025
Declarations
:
: Approval was obtained from the ethics committee of Chulalongkorn University (IRB no. 1156/2024). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The approval of retrieving retrospective data from electronic medical records (EMR) was made and informed consent was waived by IRBREC.
: The authors declare no competing interests.
: SR and AH report no significant conflict of interest related to this topic. PA has received speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, and ZP Therapeutics. TP has received speaker honoraria from BL HUA, Daiichi Sankyo, Eisai, Lundbeck, Pfizer, Servier, and ZP Therapeutics. ST reports speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris, and ZP Therapeutics. WR declares receiving speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris, and ZP Therapeutics.